Alispahic, I.A.; Eklöf, J.; Sivapalan, P.; Jordan, A.R.; Harboe, Z.B.; Biering-Sørensen, T.; Jensen, J.-U.S.
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin. J. Clin. Med. 2024, 13, 1987.
https://doi.org/10.3390/jcm13071987
AMA Style
Alispahic IA, Eklöf J, Sivapalan P, Jordan AR, Harboe ZB, Biering-Sørensen T, Jensen J-US.
Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin. Journal of Clinical Medicine. 2024; 13(7):1987.
https://doi.org/10.3390/jcm13071987
Chicago/Turabian Style
Alispahic, Imane Achir, Josefin Eklöf, Pradeesh Sivapalan, Alexander Ryder Jordan, Zitta Barrella Harboe, Tor Biering-Sørensen, and Jens-Ulrik Stæhr Jensen.
2024. "Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin" Journal of Clinical Medicine 13, no. 7: 1987.
https://doi.org/10.3390/jcm13071987
APA Style
Alispahic, I. A., Eklöf, J., Sivapalan, P., Jordan, A. R., Harboe, Z. B., Biering-Sørensen, T., & Jensen, J.-U. S.
(2024). Risk of Mortality and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease Treated with Azithromycin, Roxithromycin, Clarithromycin, and Amoxicillin. Journal of Clinical Medicine, 13(7), 1987.
https://doi.org/10.3390/jcm13071987